ArticleJTO clinical and research reports2025

Primary Results from IMscin002: A Study to Evaluate Patient Preferences and Perceptions of Health Care Professionals for Atezolizumab Subcutaneous Versus Intravenous for the Treatment of NSCLC.

Federico Cappuzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.